• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Germany

rocketship new blast off start up business development break off acquisition split
CRO

Velocity accelerates growth with buys in Poland and Germany

Velocity Clinical Research has expanded its footprint in Europe with the acquisitions of three clinical site networks in Poland and Germany. 
Joseph Keenan Jan 3, 2024 12:55pm
image of CSLs new RD facility

CSL Behring unveils its largest R&D site, slated to open in 2022

Sep 14, 2022 10:45am
deal

ResMed continues German expansion with Mementor buy

Aug 2, 2022 1:00pm
COVID-19 danger coronavirus pandemic quarantine

InflaRx to take failed COVID treatment to FDA anyway

Jul 26, 2022 11:20am
acquisition magnet

ResMed drops $1B on German software developer

Jun 14, 2022 10:50am
mouse

A common cancer immunotherapy target might also work in obesity

Mar 9, 2022 2:00pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings